JOSEPH SAWYER: Open Payments
NPI 1740933183 · REHOBETH, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 29 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $199 · 2025 $705
Food & beverage: $606Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $268 |
| GENZYME CORPORATION | 3 | $99 |
| CSL Behring | 3 | $71 |
| Genentech USA, Inc. | 3 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $55 |
| Ionis Pharmaceuticals, Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Amgen Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $19 |
| BioCryst US Sales Co., LLC | 1 | $17 |
Products named: DUPIXENT, Xolair, NEFFY, DAWNZERA, Hizentra, TEZSPIRE, Haegarda, ADBRY.
Industry payments across AL — which companies pay providers there.
